Reata Pharmaceuticals Inc

GEODE CAPITAL MANAGEMENT, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

593,430

Value ($000)

60,506

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	60,506	0.0%	593,430	6/30/2023
2023 Q1	5/15/2023	49,944	0.0%	549,313	3/31/2023
2022 Q4	2/13/2023	19,987	0.0%	526,116	12/31/2022
2022 Q3	11/14/2022	12,663	0.0%	503,920	9/30/2022
2022 Q2	8/12/2022	14,947	0.0%	491,865	6/30/2022
2022 Q1	5/13/2022	14,772	0.0%	450,922	3/31/2022
2021 Q4	2/11/2022	12,198	0.0%	462,581	12/31/2021
2021 Q3	11/12/2021	48,074	0.0%	477,832	9/30/2021
2021 Q2	8/13/2021	67,430	0.0%	476,443	6/30/2021
2021 Q1	5/12/2021	33,503	0.0%	336,041	3/31/2021
2020 Q4	2/12/2021	39,029	0.0%	315,722	12/31/2020
2020 Q3	11/13/2020	27,406	0.0%	281,322	9/30/2020
2020 Q2	8/13/2020	48,102	0.0%	308,307	6/30/2020
2020 Q1	5/14/2020	52,927	0.0%	366,684	3/31/2020
2019 Q4	2/13/2020	69,326	0.0%	339,122	12/31/2019